ResMed Inc. (RMD)

ResMed Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	227.89	273.71	295.28	463.16	147.13
Cash & Cash Equivalents	227.89	273.71	295.28	463.16	147.13
Cash Growth	-16.74%	-7.30%	-36.25%	214.80%	-22.03%
Receivables	704.91	575.95	614.29	474.64	528.48
Inventory	998.01	743.91	457.03	416.92	349.64
Other Current Assets	437.02	337.91	208.15	168.75	120.11
Total Current Assets	2,368	1,931	1,575	1,523	1,145
Property, Plant & Equipment	665.81	630.5	592.07	535.68	387.46
Goodwill and Intangibles	3,323	2,282	2,320	2,338	2,378
Other Long-Term Assets	395.43	251.49	240.82	189.74	196.46
Total Long-Term Assets	4,384	3,164	3,153	3,064	2,962
Total Assets	6,752	5,096	4,728	4,587	4,108
Accounts Payable	150.76	159.25	138.01	135.79	115.73
Deferred Revenue	257.26	204.12	201.11	185.92	169.81
Current Debt	31.82	31.77	35.59	33.25	11.99
Other Current Liabilities	318.7	294.16	537.07	247.8	258.46
Total Current Liabilities	758.53	689.3	911.77	602.76	555.99
Long-Term Debt	1,548	885.78	758.13	1,266	1,259
Other Long-Term Liabilities	315.19	160.03	172.55	221.58	220.64
Total Long-Term Liabilities	1,863	1,046	930.68	1,488	1,479
Total Liabilities	2,622	1,735	1,842	2,090	2,035
Total Debt	1,580	917.55	793.72	1,299	1,271
Debt Growth	72.19%	15.60%	-38.91%	2.24%	351.53%
Retained Earnings	4,253	3,614	3,080	2,833	2,436
Comprehensive Income	-272.53	-312.75	-193.49	-283.98	-253.01
Shareholders' Equity	4,130	3,361	2,886	2,497	2,072
Net Cash / Debt	-1,352.02	-643.84	-498.44	-836.11	-1,123.73
Net Cash Per Share	-9.17	-4.38	-3.40	-5.74	-7.78
Working Capital	1,609	1,242	662.99	920.7	589.38
Book Value Per Share	28.14	23.01	19.86	17.30	14.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).